A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Background: The clinical spectrum of COVID-19 is variable and ranges from asymptomatic, mildly symptomatic, moderately severe and severe disease. A small proportion might develop severe disease and may have cytokine storm. One of the therapeutic options to treat such cases is Tocilizumab (TCZ). In t...

Descripción completa

Detalles Bibliográficos
Autores principales: AlBahrani, Salma, Al-Tawfiq, Jaffar A., Alshaer, Abdulaziz R., Shilash, Amal, Alswefy, Khalid, Al-Zayer, Razan Salamah, Abouelela, Amr Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242122/
https://www.ncbi.nlm.nih.gov/pubmed/33605118
http://dx.doi.org/10.2991/jegh.k.210112.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242122/
https://www.ncbi.nlm.nih.gov/pubmed/33605118
http://dx.doi.org/10.2991/jegh.k.210112.001

Ejemplares similares